A subpopulation of CD4+ T cells can be influenced by TGFβ stimulation and then be differentiated into interleukin 17 (IL-17)-secreting CD4+ T cells (known as Th17) that acquired additional immune-suppressive (that is, tumor-promoting) function [34,35,36]. This evidence concerns the gene CD4 and neoplasm.